Navigation Links
Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
Date:10/14/2009

MOUNTAIN VIEW, Calif. and ST. LOUIS, Oct. 14 /PRNewswire/ -- Cardiva Medical, Inc. announces today that its President, Glenn Foy, will depart the organization to assume the position of Chief Executive Officer at Innovative Energy, Inc., an alternative energy company.

Augustine Lien, Founder and CEO of Cardiva Medical stated, "I would like to thank Glenn for his contributions to Cardiva over the past six years. During his tenure as President, we have transformed Cardiva from an early stage start-up to a commercial medical device company with a world-class product development, manufacturing and sales organization and significant revenues." Mr. Lien added, "With our recent successful launch of Cardiva Catalyst(TM) III, we are well positioned to lead the large vessel closure market and I wish Glenn the best as he assumes his new role at Innovative Energy."

"We are thrilled that Glenn will be joining the executive team at Innovative Energy," said Andy Schlote, Founder, Chairman and CTO of Innovative Energy, Inc. "His broad range of experience and his leadership ability make him the ideal choice to transition Innovative Energy from a product development company to a commercial frontrunner in the renewable, clean energy space." Mr. Schlote continued, "As we prepare to deliver on our first power delivery contract, Glenn's long track record of commercial successes will be a significant asset."

"I appreciate the opportunity I've been given at Cardiva and am proud of our many accomplishments as a team," added Glenn Foy. "I am very excited about my new role at Innovative Energy. They have developed truly transformational technology that will allow municipalities to locally generate renewable, clean energy at a lower cost than purchasing electricity derived from conventional fossil fuels." Foy continued, "Limiting fossil fuels and their enormous environmental impact in electricity generation is a global initiative. Innovative Energy has developed the technology that will allow it to lead in this effort."

About Cardiva Medical, Inc.

Cardiva Medical, Inc., a privately held medical device company that designs, develops and commercializes endovascular products which help the body heal itself. In 2005, Cardiva launched its first product into the vessel closure market, the Boomerang® Wire System, which demonstrated unsurpassed ease-of-use and safety. In January 2008, Cardiva launched the Cardiva Catalyst II, which incorporates hemostatic agents to accelerate the body's own coagulation pathway; quickly facilitating hemostasis at the arteriotomy site, preserving the artery and leaving absolutely nothing behind in the patient. In May 2009, Cardiva launched its latest vessel closure system, the Cardiva Catalyst III device, which is indicated for use in heparinized patients undergoing diagnostic and/or interventional femoral artery catheterization procedures using 5F, 6F, or 7F introducer sheaths. In 2006, Cardiva was presented the prestigious Frost & Sullivan Award which recognizes entrepreneurial excellence in the U.S. angioplasty and vascular closure devices market. For additional information about Cardiva, please visit our website at www.cardivamedical.com.

About Innovative Energy, Inc.

Innovative Energy, Inc., a privately held energy company, located in St. Louis, Missouri that designs, develops, and produces power plants capable of generating renewable, clean energy locally that cost less than traditional fossil fuels. Founded in 2001, the Company has had numerous patents issued in the US and worldwide on its technology and expects to launch its technology into the United States early in 2010. For additional information, please visit our website at www.innovativeenergyinc.com.

    Media Contact for Cardiva Medical Inc.:
    Mac Farnsworth, VP and CFO
    Cardiva Medical, Inc.
    Phone: 408.470.7118
    Fax: 408.212.9889
    mac_farnsworth@cardivamedical.com

    Media Contact for Innovative Energy Inc.:
    Andy Schlote, Founder, Chairman and CTO
    Innovative Energy, Inc.
    Phone: 636.600.1230
    Fax: 636.600.1231
    aschlote@iei-us.com

Cardiva Catalyst, Boomerang and Boomerang Catalyst are trademarks/registered trademarks of Cardiva Medical, Inc.

SOURCE Cardiva Medical, Inc.


'/>"/>
SOURCE Cardiva Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
2. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
3. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
4. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
5. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
6. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... JERUSALEM , May 9, 2017  Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... today that the Canadian Intellectual Property Office has ... for Oral Administration of Exenatide". The patent covers ... analog. GLP-1 is an incretin hormone ...
(Date:5/8/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its ... health care service center company based in ... relationship management programs for leading pharmaceutical manufacturers and health ... WRB will join Envoy Health Management, LLC , ... biotech firms, and other service companies. Together, WRB and ...
Breaking Medicine Technology:
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... 24, 2017 , ... Drs. Nicholas Rallis and Chris Chondrogiannis ... 10 years as clinical instructors for the reputable Full Mouth Rehabilitation continuing education ... program, private practitioners receive cutting-edge clinical training and learn how to perform ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... Global Policy Solutions is vehemently opposed to Donald Trump’s budget, “A New Foundation ... despair that inspires fear, demonizes the poor, marginalizes underserved populations, undermines productivity, and ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... tract in which the endometrial lining of the uterus spreads into the ... Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding may ...
(Date:5/24/2017)... ... ... If you are thinking of a visit to San Francisco , fall is a ... time to visit. , Business Architecture Associates is pleased to offer 5 days of training ... 4-½ day package for individuals, and as 4-½ day corporate package for up to 3 ...
Breaking Medicine News(10 mins):